Acetohydroxamic Acid Production Cost Reports

The report provides a detailed analysis essential for establishing an Acetohydroxamic Acid manufacturing plant. It encompasses all critical aspects necessary for Acetohydroxamic Acid production, including the cost of Acetohydroxamic Acid production, Acetohydroxamic Acid plant cost, Acetohydroxamic Acid production costs, and the overall Acetohydroxamic Acid manufacturing plant cost. Additionally, the study covers specific expenditures associated with setting up and operating an Acetohydroxamic Acid production plant. These encompass manufacturing processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Acetohydroxamic Acid (AHA) is mainly used in the medical field to treat urinary tract infections caused by urea-splitting bacteria, such as proteus species, especially Helicobacter pylori. It is also used in the prevention of struvite kidney stones, which are kidney stones formed in the urinary tract as a result of infection originating from urease-positive bacteria. AHA functions by inhibiting the enzyme urease and reducing ammonia production in the urine, thus lowers the pH of urine and prevents the development of struvite stones in the kidney.

Additionally, it elevates the efficacy of certain antibiotics and is therefore employed in long-term use in patients in order to manage the inhibition of urease and prevent recurrence. Furthermore, it also acts as a chelating agent for heavy metals such as iron, cobalt, nickel, copper, chromium, manganese, and uranium. It has also been reported as a partitioning agent for the separation of uranium and plutonium in nuclear fuel reprocessing.

The market for Acetohydroxamic Acid is driven by its use as a supplementary drug for the extended treatment of chronic infections in the urinary system leading to its high demand in the pharmaceutical and medical sector. Its role in preventing struvite kidney stones amplifies its market in the medical sector. In addition, its ability to improve the effectiveness of antibiotics contributes to its growing demand. Also, its employment as a long-term therapy in patients with chronic urea-splitting infections promotes its value in the market. Further, its utilization as a chelating agent for heavy metals and a partitioning agent boosts its demand even more. Overall, industrial Acetohydroxamic Acid procurement is influenced by its application in the pharmaceutical and medical industries, its ability to elevate the efficacy of antibiotics, its employment as a long-term therapy, and its utilization as a chelating and partitioning agent.

Raw Material for Acetohydroxamic Acid Production

According to the Acetohydroxamic Acid manufacturing plant project report, the key raw materials used in the production of Acetohydroxamic Acid include ethyl acetate or acetic anhydride; acetyl chloride.

Manufacturing Process of Acetohydroxamic Acid

The extensive Acetohydroxamic Acid production cost report consists of the following major industrial manufacturing processes:

1. Production from ethyl acetate or acetic anhydride: The manufacturing process of Acetohydroxamic Acid involves the reaction of ethyl acetate or acetic anhydride with hydroxylamine in the presence of absolute alcohol. The reaction occurs at ambient conditions and with a stoichiometric ratio of sodium alkoxide to synthesize Acetohydroxamic Acid.
2. Production from acetyl chloride: The process involves the reaction of Acetyl Chloride with hydroxylamine in the presence of sodium carbonate in an ether/water mixture to give the Acetohydroxamic acid.

Acetohydroxamic Acid (AHA), commercially known as Lithostat (US) or Uronefrex (EU), is a white crystalline solid having the molecular formula C2H5NO2 and a molecular weight of 75.07 g/mol. It has a melting point in the range of 89-92 °C. It has a solubility of around 1000000mg/L. The value of its partition coefficient, log P is -1.59. The value of its dissociation constant, pKa, is 8.7 at 25 °C. It releases harmful fumes of nitroxides upon decomposition.